The Warburg effect: Insights from the past decade

Pharmacology and Therapeutics

Volumn 137, Issue 3, 2013, Pages 318-330

  Upadhyay, Mohita ^a   Samal, Jasmine ^a   Kandpal, Manish ^a   Singh, Om Vir ^b   Vivekanandan, Perumal ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Epigenetics; Hypoxia inducible factor 1 (HIF1); Keywords; miRNA; Post translational modifications; Tumor microenvironment; Warburg effect (aerobic glycolysis)

Indexed keywords

2 METHOXYOESTRADIOL; 4 [BIS(2 CHLOROETHYL)OXIDOAMINO]PHENYLALANINE; 6 AMINONICOTINAMIDE; ANTINEOPLASTIC AGENT; BROMOPYRUVIC ACID; CELL NUCLEUS DNA; DEOXYCORTICOSTERONE ACETATE; DEOXYGLUCOSE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLLYSYLCYSTEINYLTHREONINAMIDE 2,6 DISULFIDE; DIGOXIN; ECHINOMYCIN; GELDANAMYCIN; GLUCOSE 6 PHOSPHATE; GLUTAMINE; HYPOXIA INDUCIBLE FACTOR 1; IMATINIB; JASMONIC ACID METHYL ESTER; LIFICIGUAT; LONIDAMINE; MANNOHEPTULOSE; MICRORNA; OXYTHIAMINE; PHLORETIN; TOPOTECAN; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; DRUG MECHANISM; ENERGY YIELD; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GLYCOLYSIS; HUMAN; MITOCHONDRIAL RESPIRATION; MOLECULAR MECHANICS; NONHUMAN; ONCOGENE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE PHOSPHORYLATION UNCOUPLING; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE; WARBURG EFFECT;

ANIMALS; GLYCOLYSIS; HUMANS; NEOPLASMS;

EID: 84874118537     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.11.003     Document Type: Review

References (214)

1. A. Ahmad, A. Aboukameel, D. Kong, Z. Wang, S. Sethi, W. Chen, F.H. Sarkar, and A. Raz Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells Cancer Res 71 2011 3400 3409
2. B. Alberts, A. Johnson, A. Lewis, M. Raff, K. Roberts, and P. Walter Molecular biology of the cell 2002 Garland Publishers New York
3. W.G. Alleman, R.L. Tabios, G.V. Chandramouli, O.N. Aprelikova, C. Torres-Cabala, A. Mendoza, C. Rogers, N.A. Sopko, W.M. Linehan, and J.R. Vasselli The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2′-deoxycytidine Clin Cancer Res 10 2004 7011 7021
4. B.P. Ashburner, S.D. Westerheide, and A.S. Baldwin Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression Mol Cell Biol 21 2001 7065 7077
5. D. Astuti, F. Latif, A. Dallol, P.L. Dahia, F. Douglas, E. George, F. Skoldberg, E.S. Husebye, C. Eng, and E.R. Maher Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma Am J Hum Genet 69 2001 49 54
6. K.K. Au, E. Liong, J.Y. Li, P.S. Li, C.C. Liew, T.T. Kwok, Y.M. Choy, C.Y. Lee, and K.P. Fung Increases in mRNA levels of glucose transporters types 1 and 3 in Ehrlich ascites tumor cells during tumor development J Cell Biochem 67 1997 131 135
7. V. Ayyasamy, K.M. Owens, M.M. Desouki, P. Liang, A. Bakin, K. Thangaraj, D.J. Buchsbaum, A.F. LoBuglio, and K.K. Singh Cellular model of Warburg effect identifies tumor promoting function of UCP2 in breast cancer and its suppression by genipin PLoS One 6 2011
8. H. Bando, T. Atsumi, T. Nishio, H. Niwa, S. Mishima, C. Shimizu, N. Yoshioka, R. Bucala, and T. Koike Phosphorylation of the 6-phosphofructo-2- kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer Clin Cancer Res 11 2005 5784 5792
9. K. Barnes, E. McIntosh, A.D. Whetton, G.Q. Daley, J. Bentley, and S.A. Baldwin Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation Oncogene 24 2005 3257 3267
10. R. Bartrons, and J. Caro Hypoxia, glucose metabolism and the Warburg's effect J Bioenerg Biomembr 39 2007 223 229
11. B.E. Baysal, R.E. Ferrell, J.E. Willett-Brozick, E.C. Lawrence, D. Myssiorek, A. Bosch, M.e.A. van der, P.E. Taschner, W.S. Rubinstein, E.N. Myers, C.W. Richard III, C.J. Cornelisse, P. Devilee, and B. Devlin Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma Science 287 2000 848 851
12. K. Bensaad, A. Tsuruta, M.A. Selak, M.N. Vidal, K. Nakano, R. Bartrons, E. Gottlieb, and K.H. Vousden TIGAR, a p53-inducible regulator of glycolysis and apoptosis Cell 126 2006 107 120
13. J. Berg, J. Tymoczko, and L. Stryer Biochemistry 2002 W.H Freeman & Co. New York
14. J.M. Bertoni Competitive inhibition of rat brain hexokinase by 2-deoxyglucose, glucosamine, and metrizamide J Neurochem 37 1981 1523 1528
15. M. Board, A. Colquhoun, and E.A. Newsholme High Km glucose- phosphorylating (glucokinase) activities in a range of tumor cell lines and inhibition of rates of tumor growth by the specific enzyme inhibitor mannoheptulose Cancer Res 55 1995 3278 3285
16. L. Bosch-Presegue, and A. Vaquero The dual role of sirtuins in cancer Genes Cancer 2 2011 648 662
17. R.S. Brown, and R.L. Wahl Overexpression of GLUT-1 glucose transporter in human breast cancer. An immunohistochemical study Cancer 72 1993 2979 2985
18. U. Bruning, L. Cerone, Z. Neufeld, S.F. Fitzpatrick, A. Cheong, C.C. Scholz, D.A. Simpson, M.O. Leonard, M.M. Tambuwala, E.P. Cummins, and C.T. Taylor MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia Mol Cell Biol 31 2011 4087 4096
19. C.L. Buller, R.D. Loberg, M.H. Fan, Q. Zhu, J.L. Park, E. Vesely, K. Inoki, K.L. Guan, and F.C. Brosius III A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression Am J Physiol Cell Physiol 295 2008 C836 C843
20. R.A. Cairns, I. Harris, S. McCracken, and T.W. Mak Cancer cell metabolism Cold Spring Harb Symp Quant Biol 76 2011 299 311
21. R.A. Cairns, I. Papandreou, P.D. Sutphin, and N.C. Denko Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy Proc Natl Acad Sci U S A 104 2007 9445 9450
22. X. Cao, L. Fang, S. Gibbs, Y. Huang, Z. Dai, P. Wen, X. Zheng, W. Sadee, and D. Sun Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia Cancer Chemother Pharmacol 59 2007 495 505
23. S.Y. Chan, Y.Y. Zhang, C. Hemann, C.E. Mahoney, J.L. Zweier, and J. Loscalzo MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2 Cell Metab 10 2009 273 284
24. J.M. Chang, J.W. Chung, H.J. Jae, H. Eh, K.R. Son, K.C. Lee, and J.H. Park Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: in vivo investigation in normal rabbit model Acad Radiol 14 2007 85 92
25. W. Chen, and M. Gueron The inhibition of bovine heart hexokinase by 2-deoxy-d-glucose-6-phosphate: characterization by 31P NMR and metabolic implications Biochimie 74 1992 867 873
26. X. Chen, X. Guo, H. Zhang, Y. Xiang, J. Chen, Y. Yin, X. Cai, K. Wang, G. Wang, Y. Ba, L. Zhu, J. Wang, R. Yang, Y. Zhang, Z. Ren, K. Zen, J. Zhang, and C.Y. Zhang Role of miR-143 targeting KRAS in colorectal tumorigenesis Oncogene 28 2009 1385 1392
27. Z. Chen, W. Lu, C. Garcia-Prieto, and P. Huang The Warburg effect and its cancer therapeutic implications J Bioenerg Biomembr 39 2007 267 274
28. W. Chen, Z. Sun, X.J. Wang, T. Jiang, Z. Huang, D. Fang, and D.D. Zhang Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response Mol Cell 34 2009 663 673
29. M. Chen, J. Zhang, N. Li, Z. Qian, M. Zhu, Q. Li, J. Zheng, X. Wang, and G. Shi Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer PLoS One 6 2011
30. J. Cheng, X. Kang, S. Zhang, and E.T. Yeh SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia Cell 131 2007 584 595
31. G. Cheng, J. Zielonka, B.P. Dranka, D. McAllister, A.C. Mackinnon Jr., J. Joseph, and B. Kalyanaraman Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death Cancer Res 72 2012 2634 2644
32. H.R. Christofk, M.G. Vander Heiden, M.H. Harris, A. Ramanathan, R.E. Gerszten, R. Wei, M.D. Fleming, S.L. Schreiber, and L.C. Cantley The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Nature 452 2008 230 233
33. B. Clem, S. Telang, A. Clem, A. Yalcin, J. Meier, A. Simmons, M.A. Rasku, S. Arumugam, W.L. Dean, J. Eaton, A. Lane, J.O. Trent, and J. Chesney Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth Mol Cancer Ther 7 2008 110 120
34. D. Colomer, J.L. Vives-Corrons, A. Pujades, and R. Bartrons Control of phosphofructokinase by fructose 2,6-bisphosphate in B-lymphocytes and B-chronic lymphocytic leukemia cells Cancer Res 47 1987 1859 1862
35. G.M. Couper The cell: a molecular approach 2000 ASM Press Washington
36. J.M. Cuezva, M. Sanchez-Arago, S. Sala, A. Blanco-Rivero, and A.D. Ortega A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer J Bioenerg Biomembr 39 2007 259 265
37. R. Dagher, M. Cohen, G. Williams, M. Rothmann, J. Gobburu, G. Robbie, A. Rahman, G. Chen, A. Staten, D. Griebel, and R. Pazdur Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors Clin Cancer Res 8 2002 3034 3038
38. C.V. Dang Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle 9 2010 3884 3886
39. C.V. Dang, J.W. Kim, P. Gao, and J. Yustein The interplay between MYC and HIF in cancer Nat Rev Cancer 8 2008 51 56
40. R.J. DeBerardinis, J.J. Lum, G. Hatzivassiliou, and C.B. Thompson The biology of cancer: metabolic reprogramming fuels cell growth and proliferation Cell Metab 7 2008 11 20
41. L.A. Demetrius, J.F. Coy, and J.A. Tuszynski Cancer proliferation and therapy: the Warburg effect and quantum metabolism Theor Biol Med Model 7 2010 2
42. N.C. Denko Hypoxia, HIF1 and glucose metabolism in the solid tumour Nat Rev Cancer 8 2008 705 713
43. J. Deprez, D. Vertommen, D.R. Alessi, L. Hue, and M.H. Rider Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades J Biol Chem 272 1997 17269 17275
44. G. Di Chiro, R.L. DeLaPaz, R.A. Brooks, L. Sokoloff, P.L. Kornblith, B.H. Smith, N.J. Patronas, C.V. Kufta, R.M. Kessler, G.S. Johnston, R.G. Manning, and A.P. Wolf Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography Neurology 32 1982 1323 1329
45. P. Ditonno, M. Battaglia, O. Selvaggio, L. Garofalo, V. Lorusso, and F.P. Selvaggi Clinical evidence supporting the role of lonidamine for the treatment of BPH Rev Urol 7 Suppl. 7 2005 S27 S33
46. K. Duvel, J.L. Yecies, S. Menon, P. Raman, A.I. Lipovsky, A.L. Souza, E. Triantafellow, Q. Ma, R. Gorski, S. Cleaver, M.G. Vander Heiden, J.P. MacKeigan, P.M. Finan, C.B. Clish, L.O. Murphy, and B.D. Manning Activation of a metabolic gene regulatory network downstream of mTOR complex 1 Mol Cell 39 2010 171 183
47. A. El Ouaamari, N. Baroukh, G.A. Martens, P. Lebrun, D. Pipeleers, and E. van Obberghen miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells Diabetes 57 2008 2708 2717
48. M.M. Fabani, and M.J. Gait miR-122 targeting with LNA/2′-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates RNA 14 2008 336 346
49. J. Fan, T. Hitosugi, T.W. Chung, J. Xie, Q. Ge, T.L. Gu, R.D. Polakiewicz, G.Z. Chen, T.J. Boggon, S. Lonial, F.R. Khuri, S. Kang, and J. Chen Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells Mol Cell Biol 31 2011 4938 4950
50. R. Fang, T. Xiao, Z. Fang, Y. Sun, F. Li, Y. Gao, Y. Feng, L. Li, Y. Wang, X. Liu, H. Chen, X.Y. Liu, and H. Ji MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene J Biol Chem 29 2012 23227 23235
51. E. Favaro, A. Ramachandran, R. McCormick, H. Gee, C. Blancher, M. Crosby, C. Devlin, C. Blick, F. Buffa, J.L. Li, B. Vojnovic, N.e.R. Pires das, P. Glazer, F. Iborra, M. Ivan, J. Ragoussis, and A.L. Harris MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU PLoS One 5 2010
52. E.C. Ferguson, and J.C. Rathmell New roles for pyruvate kinase M2: working out the Warburg effect Trends Biochem Sci 33 2008 359 362
53. L.W. Finley, A. Carracedo, J. Lee, A. Souza, A. Egia, J. Zhang, J. Teruya-Feldstein, P.I. Moreira, S.M. Cardoso, C.B. Clish, P.P. Pandolfi, and M.C. Haigis SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization Cancer Cell 19 2011 416 428
54. J.D. Firth, B.L. Ebert, and P.J. Ratcliffe Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements J Biol Chem 270 1995 21021 21027
55. A. Floridi, M.G. Paggi, S. D'Atri, C. De Martino, M.L. Marcante, B. Silvestrini, and A. Caputo Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells Cancer Res 41 1981 4661 4666
56. P. Flynn, M. Wongdagger, M. Zavar, N.M. Dean, and D. Stokoe Inhibition of PDK-1 activity causes a reduction in cell proliferation and survival Curr Biol 10 2000 1439 1442
57. F. Fornari, M. Milazzo, P. Chieco, M. Negrini, G.A. Calin, G.L. Grazi, D. Pollutri, C.M. Croce, L. Bolondi, and L. Gramantieri MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells Cancer Res 70 2010 5184 5193
58. S. Ganapathy-Kanniappan, J.F. Geschwind, R. Kunjithapatham, M. Buijs, J.A. Vossen, I. Tchernyshyov, R.N. Cole, L.H. Syed, P.P. Rao, S. Ota, and M. Vali Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death Anticancer Res 29 2009 4909 4918
59. K. Garber Energy deregulation: licensing tumors to grow Science 312 2006 1158 1159
60. R.A. Gatenby, and R.J. Gillies Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4 2004 891 899
61. A.K. Ghosh, T.D. Shanafelt, A. Cimmino, C. Taccioli, S. Volinia, C.G. Liu, G.A. Calin, C.M. Croce, D.A. Chan, A.J. Giaccia, C. Secreto, L.E. Wellik, Y.K. Lee, D. Mukhopadhyay, and N.E. Kay Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells Blood 113 2009 5568 5574
62. G. Ghosh, I.V. Subramanian, N. Adhikari, X. Zhang, H.P. Joshi, D. Basi, Y.S. Chandrashekhar, J.L. Hall, S. Roy, Y. Zeng, and S. Ramakrishnan Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis J Clin Invest 120 2010 4141 4154 (LID - 10.1172/JCI)
63. R.J. Gillies, I. Robey, and R.A. Gatenby Causes and consequences of increased glucose metabolism of cancers J Nucl Med 49 Suppl. 2 2008 24S 42S
64. J.M. Gleadle, and P.J. Ratcliffe Hypoxia and the regulation of gene expression Mol Med Today 4 1998 122 129
65. J. Godlewski, M.O. Nowicki, A. Bronisz, G. Nuovo, J. Palatini, M. De Lay, J. Van Brocklyn, M.C. Ostrowski, E.A. Chiocca, and S.E. Lawler MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells Mol Cell 37 2010 620 632
66. A. Goel, S.P. Mathupala, and P.L. Pedersen Glucose metabolism in cancer. Evidence that demethylation events play a role in activating type II hexokinase gene expression J Biol Chem 278 2003 15333 15340
67. V. Gogvadze, S. Orrenius, and B. Zhivotovsky Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 18 2008 165 173
68. J.D. Gordan, J.A. Bertout, C.J. Hu, J.A. Diehl, and M.C. Simon HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity Cancer Cell 11 2007 335 347
69. J.D. Gordan, C.B. Thompson, and M.C. Simon HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation Cancer Cell 12 2007 108 113
70. E. Gottlieb, and I.P. Tomlinson Mitochondrial tumour suppressors: a genetic and biochemical update Nat Rev Cancer 5 2005 857 866
71. K. Gottlob, N. Majewski, S. Kennedy, E. Kandel, R.B. Robey, and N. Hay Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase Genes Dev 15 2001 1406 1418
72. L.H. Gregersen, A. Jacobsen, L.B. Frankel, J. Wen, A. Krogh, and A.H. Lund microRNA-143 down-regulates Hexokinase 2 in colon cancer cells BMC Cancer 12 2012 232
73. C. Guo, J.F. Sah, L. Beard, J.K. Willson, S.D. Markowitz, and K. Guda The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers Genes Chromosomes Cancer 47 2008 939 946
74. D.G. Hardie The AMP-activated protein kinase pathway-new players upstream and downstream J Cell Sci 117 2004 5479 5487
75. F.P. Herter, S.G. Weissman, H.G. Thompson Jr., G. Hyman, and D.S. Martin Clinical experience with 6-aminonicotinamide Cancer Res 21 1961 31 37
76. F. Hirschhaeuser, U.G. Sattler, and W. Mueller-Klieser Lactate: a metabolic key player in cancer Cancer Res 15 2011 6921 6925
77. M.J. Hitchler, and F.E. Domann Metabolic defects provide a spark for the epigenetic switch in cancer Free Radic Biol Med 47 2009 115 127
78. T. Hitosugi, J. Fan, T.W. Chung, K. Lythgoe, X. Wang, J. Xie, Q. Ge, T.L. Gu, R.D. Polakiewicz, J.L. Roesel, G.Z. Chen, T.J. Boggon, S. Lonial, H. Fu, F.R. Khuri, S. Kang, and J. Chen Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism Mol Cell 44 2011 864 877
79. T. Hitosugi, S. Kang, M.G. Vander Heiden, T.W. Chung, S. Elf, K. Lythgoe, S. Dong, S. Lonial, X. Wang, G.Z. Chen, J. Xie, T.L. Gu, R.D. Polakiewicz, J.L. Roesel, T.J. Boggon, F.R. Khuri, D.G. Gilliland, L.C. Cantley, and Kaufm Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth Sci Signal 2 2009
80. M. Hockel, and P. Vaupel Biological consequences of tumor hypoxia Semin Oncol 28 2001 36 41
81. T. Horie, K. Ono, H. Nishi, Y. Iwanaga, K. Nagao, M. Kinoshita, Y. Kuwabara, R. Takanabe, K. Hasegawa, T. Kita, and T. Kimura MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes Biochem Biophys Res Commun 389 2009 315 320
82. W. Hu, C.S. Chan, R. Wu, C. Zhang, Y. Sun, J.S. Song, L.H. Tang, A.J. Levine, and Z. Feng Negative regulation of tumor suppressor p53 by microRNA miR-504 Mol Cell 38 2010 689 699
83. W. Hu, C. Zhang, R. Wu, Y. Sun, A. Levine, and Z. Feng Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function Proc Natl Acad Sci U S A 107 2010 7455 7460
84. D.Y. Hwang, and F. Ismail-Beigi Control of Glut1 promoter activity under basal conditions and in response to hyperosmolarity: role of Sp1 Am J Physiol Cell Physiol 290 2006 C337 C344
85. J.S. Isaacs, Y.J. Jung, E.G. Mimnaugh, A. Martinez, F. Cuttitta, and L.M. Neckers Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway J Biol Chem 277 2002 29936 29944
86. J.S. Isaacs, Y.J. Jung, D.R. Mole, S. Lee, C. Torres-Cabala, Y.L. Chung, M. Merino, J. Trepel, B. Zbar, J. Toro, P.J. Ratcliffe, W.M. Linehan, and L. Neckers HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability Cancer Cell 8 2005 143 153
87. A. Isidoro, M. Martinez, P.L. Fernandez, A.D. Ortega, G. Santamaria, M. Chamorro, J.C. Reed, and J.M. Cuezva Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer Biochem J 378 2004 17 20
88. S. Jiang, L.F. Zhang, H.W. Zhang, S. Hu, M.H. Lu, S. Liang, B. Li, Y. Li, D. Li, E.D. Wang, and M.F. Liu A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells EMBO J 31 2012 1985 1998 (LID - 10.1038/emb)
89. S.M. Johnson, H. Grosshans, J. Shingara, M. Byrom, R. Jarvis, A. Cheng, E. Labourier, K.L. Reinert, D. Brown, and F.J. Slack RAS is regulated by the let-7 microRNA family Cell 120 2005 635 647
90. R.G. Jones, D.R. Plas, S. Kubek, M. Buzzai, J. Mu, Y. Xu, M.J. Birnbaum, and C.B. Thompson AMP-activated protein kinase induces a p53-dependent metabolic checkpoint Mol Cell 18 2005 283 293
91. R.G. Jones, and C.B. Thompson Tumor suppressors and cell metabolism: a recipe for cancer growth Genes Dev 23 2009 537 548
92. W.G. Kaelin The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing Cold Spring Harb Symp Quant Biol 70 2005 159 166
93. R. Kannagi Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited Glycoconj J 20 2004 353 364
94. B. Kefas, L. Comeau, N. Erdle, E. Montgomery, S. Amos, and B. Purow Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells Neuro Oncol 12 2010 1102 1112
95. T.J. Kelly, A.L. Souza, C.B. Clish, and P. Puigserver A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like Mol Cell Biol 31 2011 2696 2706
96. O.A. Kent, R.R. Chivukula, M. Mullendore, E.A. Wentzel, G. Feldmann, K.H. Lee, S. Liu, S.D. Leach, A. Maitra, and J.T. Mendell Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway Genes Dev 24 2010 2754 2759
97. J.W. Kim, and C.V. Dang Cancer's molecular sweet tooth and the Warburg effect Cancer Res 66 2006 8927 8930
98. S.H. Kim, and G.M. Lee Down-regulation of lactate dehydrogenase-A by siRNAs for reduced lactic acid formation of Chinese hamster ovary cells producing thrombopoietin Appl Microbiol Biotechnol 74 2007 152 159
99. J.W. Kim, I. Tchernyshyov, G.L. Semenza, and C.V. Dang HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia Cell Metab 3 2006 177 185
100. E. Kohler, H. Barrach, and D. Neubert Inhibition of NADP dependent oxidoreductases by the 6-aminonicotinamide analogue of NADP FEBS Lett 6 1970 225 228
101. T. Koike, N. Kimura, K. Miyazaki, T. Yabuta, K. Kumamoto, S. Takenoshita, J. Chen, M. Kobayashi, M. Hosokawa, A. Taniguchi, T. Kojima, N. Ishida, M. Kawakita, H. Yamamoto, H. Takematsu, A. Suzuki, Y. Kozutsumi, and R. Kannagi Hypoxia induces adhesion molecules on cancer cells: a missing link between Warburg effect and induction of selectin-ligand carbohydrates Proc Natl Acad Sci U S A 101 2004 8132 8137
102. H. Kondoh, M.E. Lleonart, J. Gil, J. Wang, P. Degan, G. Peters, D. Martinez, A. Carnero, and D. Beach Glycolytic enzymes can modulate cellular life span Cancer Res 65 2005 177 185
103. W.H. Koppenol, P.L. Bounds, and C.V. Dang Otto Warburg's contributions to current concepts of cancer metabolism Nat Rev Cancer 11 2011 325 337
104. M. Koshiji, Y. Kageyama, E.A. Pete, I. Horikawa, J.C. Barrett, and L.E. Huang HIF-1alpha induces cell cycle arrest by functionally counteracting Myc EMBO J 23 2004 1949 1956
105. M. Kumar, Z. Lu, A.A. Takwi, W. Chen, N.S. Callander, K.S. Ramos, K.H. Young, and Y. Li Negative regulation of the tumor suppressor p53 gene by microRNAs Oncogene 30 2011 843 853
106. A. Lagana, J. Vadnais, P.U. Le, T.N. Nguyen, R. Laprade, I.R. Nabi, and J. Noel Regulation of the formation of tumor cell pseudopodia by the Na(+)/H(+) exchanger NHE1 J Cell Sci 113 Pt 20 2000 3649 3662
107. A. Lal, H. Peters, B. St Croix, Z.A. Haroon, M.W. Dewhirst, R.L. Strausberg, J.H. Kaanders, K.o.A. van der, and G.J. Riggins Transcriptional response to hypoxia in human tumors J Natl Cancer Inst 93 2001 1337 1343
108. M. Laplante, and D.M. Sabatini An emerging role of mTOR in lipid biosynthesis Curr Biol 19 2009 R1046 R1052
109. M.T. Le, C. Teh, N. Shyh-Chang, H. Xie, B. Zhou, V. Korzh, H.F. Lodish, and B. Lim MicroRNA-125b is a novel negative regulator of p53 Genes Dev 23 2009 862 876
110. S.T. Lee, K. Chu, K.H. Jung, H.J. Yoon, D. Jeon, K.M. Kang, K.H. Park, E.K. Bae, M. Kim, S.K. Lee, and J.K. Roh MicroRNAs induced during ischemic preconditioning Stroke 41 2010 1646 1651
111. X. Liu, X. Wang, J. Zhang, E.K. Lam, V.Y. Shin, A.S. Cheng, J. Yu, F.K. Chan, J.J. Sung, and H.C. Jin Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis Oncogene 29 2010 442 450
112. H. Lu, R.J. Buchan, and S.A. Cook MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism Cardiovasc Res 86 2010 410 420
113. W. Lu, Y. Hu, G. Chen, Z. Chen, H. Zhang, F. Wang, L. Feng, H. Pelicano, H. Wang, M.J. Keating, J. Liu, W. McKeehan, H. Wang, Y. Luo, and P. Huang Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy PLoS Biol 10 5 2012 e1001326
114. S.Y. Lunt, and M.G. Vander Heiden Aerobic glycolysis: meeting the metabolic requirements of cell proliferation Annu Rev Cell Dev Biol 27 2011 441 464
115. W. Luo, H. Hu, R. Chang, J. Zhong, M. Knabel, R. O'Meally, R.N. Cole, A. Pandey, and G.L. Semenza Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1 Cell 145 2011 732 744
116. L. Lv, D. Li, D. Zhao, R. Lin, Y. Chu, H. Zhang, Z. Zha, Y. Liu, Z. Li, Y. Xu, G. Wang, Y. Huang, Y. Xiong, K.L. Guan, and Q.Y. Lei Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth Mol Cell 42 2011 719 730
117. W. Ma, H.J. Sung, J.Y. Park, S. Matoba, and P.M. Hwang A pivotal role for p53: balancing aerobic respiration and glycolysis J Bioenerg Biomembr 39 2007 243 246
118. N.J. Mabjeesh, D. Escuin, T.M. LaVallee, V.S. Pribluda, G.M. Swartz, M.S. Johnson, M.T. Willard, H. Zhong, J.W. Simons, and P. Giannakakou 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF Cancer Cell 3 2003 363 375
119. B.M. Madhok, S. Yeluri, S.L. Perry, T.A. Hughes, and D.G. Jayne Targeting glucose metabolism: an emerging concept for anticancer therapy Am J Clin Oncol 34 2011 628 635 (LID - 10.1097/COC)
120. J.C. Maher, N. Savaraj, W. Priebe, H. Liu, and T.J. Lampidis Differential sensitivity to 2-deoxy-d-glucose between two pancreatic cell lines correlates with GLUT-1 expression Pancreas 30 2005 e34 e39
121. A.S. Marsin, C. Bouzin, L. Bertrand, and L. Hue The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase J Biol Chem 277 2002 30778 30783
122. J.H. Marxsen, P. Stengel, K. Doege, P. Heikkinen, T. Jokilehto, T. Wagner, W. Jelkmann, P. Jaakkola, and E. Metzen Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases Biochem J 381 2004 761 767
123. G. Maschek, N. Savaraj, W. Priebe, P. Braunschweiger, K. Hamilton, G.F. Tidmarsh, L.R. De Young, and T.J. Lampidis 2-Deoxy-d-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo Cancer Res 64 2004 31 34
124. S.P. Mathupala, Y.H. Ko, and P.L. Pedersen Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria Oncogene 25 2006 4777 4786
125. S.P. Mathupala, and P.L. Pedersen Voltage dependent anion channel-1 (Vdac-1) as an anti-cancer target Cancer Biol Ther 9 2010 1053 1056
126. S. Matoba, J.G. Kang, W.D. Patino, A. Wragg, M. Boehm, O. Gavrilova, P.J. Hurley, F. Bunz, and P.M. Hwang P53 Regulates Mitochondrial Respiration Science 312 2006 1650 1653
127. S. Mazurek, C.B. Boschek, F. Hugo, and E. Eigenbrodt Pyruvate kinase type M2 and its role in tumor growth and spreading Semin Cancer Biol 15 2005 300 308
128. R.B. McComb, and W.D. Yushok Properties of particulate hexokinase of the Krebs-2 ascites tumor Biochim Biophys Acta 34 1959 515 526
129. F. Meng, R. Henson, H. Wehbe-Janek, K. Ghoshal, S.T. Jacob, and T. Patel MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology 133 2007 647 658
130. A. Menssen, P. Hydbring, K. Kapelle, J. Vervoorts, J. Diebold, B. Luscher, L.G. Larsson, and H. Hermeking The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop Proc Natl Acad Sci U S A 109 2012 E187 E196
131. E.D. Michelakis, L. Webster, and J.R. Mackey Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer Br J Cancer 99 2008 989 994
132. S. Miyamoto, A.N. Murphy, and J.H. Brown Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II Cell Death Differ 15 2008 521 529
133. D.R. Mole, P.H. Maxwell, C.W. Pugh, and P.J. Ratcliffe Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing IUBMB Life 52 2001 43 47
134. R. Moreno-Sanchez, S. Rodriguez-Enriquez, A. Marin-Hernandez, and E. Saavedra Energy metabolism in tumor cells FEBS J 274 2007 1393 1418
135. M.K. Muniyappa, P. Dowling, M. Henry, P. Meleady, P. Doolan, P. Gammell, M. Clynes, and N. Barron MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines Eur J Cancer 45 2009 3104 3118
136. A.K. Nagaraja, C.J. Creighton, Z. Yu, H. Zhu, P.H. Gunaratne, J.G. Reid, E. Olokpa, H. Itamochi, N.T. Ueno, S.M. Hawkins, M.L. Anderson, and M.M. Matzuk A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer Mol Endocrinol 24 2010 447 463
137. R.A. Nakashima, M.G. Paggi, L.J. Scott, and P.L. Pedersen Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line Cancer Res 48 1988 913 919
138. S. Niemann, and U. Muller Mutations in SDHC cause autosomal dominant paraganglioma, type 3 Nat Genet 26 2000 268 270
139. M.W. Nijsten, and G.M. van Dam Hypothesis: using the Warburg effect against cancer by reducing glucose and providing lactate Med Hypotheses 73 2009 48 51
140. M.W. Nirenberg, and J.F. Hogg Inhibition of anaerobic glycolysis in Ehrlich ascites tumor cells by 2-deoxy-d-glucose Cancer Res 18 1958 518 521
141. K.J. O'Byrne, A.M. Baird, L. Kilmartin, J. Leonard, C. Sacevich, and S.G. Gray Epigenetic regulation of glucose transporters in non-small cell lung cancer Cancers 3 2011 1550 1565
142. D.A. Okar, and A.J. Lange Fructose-2,6-bisphosphate and control of carbohydrate metabolism in eukaryotes Biofactors 10 1999 1 14
143. V. Olive, M.J. Bennett, J.C. Walker, C. Ma, I. Jiang, C. Cordon-Cardo, Q.J. Li, S.W. Lowe, G.J. Hannon, and L. He miR-19 is a key oncogenic component of mir-17-92 Genes Dev 23 2009 2839 2849
144. D. Palmieri, D. Fitzgerald, S.M. Shreeve, E. Hua, J.L. Bronder, R.J. Weil, S. Davis, A.M. Stark, M.J. Merino, R. Kurek, H.M. Mehdorn, G. Davis, S.M. Steinberg, P.S. Meltzer, K. Aldape, and P.S. Steeg Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis Mol Cancer Res 7 2009 1438 1445
145. T. Papagiannakopoulos, A. Shapiro, and K.S. Kosik MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells Cancer Res 68 2008 8164 8172
146. I. Papandreou, R.A. Cairns, L. Fontana, A.L. Lim, and N.C. Denko HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption Cell Metab 3 2006 187 197
147. T.M. Paravicini, and R.M. Touyz NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities Diabetes Care 31 Suppl. 2 2008 S170 S180
148. P. Parente, A. Coli, G. Massi, A. Mangoni, M.M. Fabrizi, and G. Bigotti Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions J Exp Clin Cancer Res 27 2008 34
149. D. Pathania, M. Millard, and N. Neamati Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism Adv Drug Deliv Rev 61 2009 1250 1275
150. P.L. Pedersen Warburg, me and Hexokinase 2: multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen J Bioenerg Biomembr 39 2007 211 222
151. H. Pelicano, D.S. Martin, R.H. Xu, and P. Huang Glycolysis inhibition for anticancer treatment Oncogene 25 2006 4633 4646
152. H. Pelicano, R.H. Xu, M. Du, L. Feng, R. Sasaki, J.S. Carew, Y. Hu, L. Ramdas, L. Hu, M.J. Keating, W. Zhang, W. Plunkett, and P. Huang Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism J Cell Biol 175 2006 913 923
153. A. Peschiaroli, A. Giacobbe, A. Formosa, E.K. Markert, L. Bongiorno-Borbone, A.J. Levine, E. Candi, A. D'Alessandro, L. Zolla, A. Finazzi Agro, and G. Melino miR-143 regulates hexokinase 2 expression in cancer cells Oncogene 2012 10.1038/onc.2012.100 (LID)
154. P.J. Pollard, J.J. Briere, N.A. Alam, J. Barwell, E. Barclay, N.C. Wortham, T. Hunt, M. Mitchell, S. Olpin, S.J. Moat, I.P. Hargreaves, S.J. Heales, Y.L. Chung, J.R. Griffiths, A. Dalgleish, J.A. McGrath, M.J. Gleeson, and Hod Accumulation of krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations Hum Mol Genet 14 2005 2231 2239
155. T.J. Pullen, X.a.G. da Silva, G. Kelsey, and G.A. Rutter miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1) Mol Cell Biol 31 2011 3182 3194
156. B. Rais, B. Comin, J. Puigjaner, J.L. Brandes, E. Creppy, D. Saboureau, R. Ennamany, W.N. Lee, L.G. Boros, and M. Cascante Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle FEBS Lett 456 1999 113 118
157. S. Rane, M. He, D. Sayed, H. Vashistha, A. Malhotra, J. Sadoshima, D.E. Vatner, S.F. Vatner, and M. Abdellatif Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes Circ Res 104 2009 879 886
158. A. Rapisarda, B. Uranchimeg, D.A. Scudiero, M. Selby, E.A. Sausville, R.H. Shoemaker, and G. Melillo Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway Cancer Res 62 2002 4316 4324
159. A. Rapisarda, B. Uranchimeg, O. Sordet, Y. Pommier, R.H. Shoemaker, and G. Melillo Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications Cancer Res 64 2004 1475 1482
160. J.C. Rathmell, C.J. Fox, D.R. Plas, P.S. Hammerman, R.M. Cinalli, and C.B. Thompson Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival Mol Cell Biol 23 2003 7315 7328
161. M. Rho, J. Kim, C.D. Jee, Y.M. Lee, H.E. Lee, M.A. Kim, H.S. Lee, and W.H. Kim Expression of type 2 hexokinase and mitochondria-related genes in gastric carcinoma tissues and cell lines Anticancer Res 27 2007 251 258
162. M.H. Rider, L. Bertrand, D. Vertommen, P.A. Michels, G.G. Rousseau, and L. Hue 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis Biochem J 381 2004 561 579
163. R.B. Robey, and N. Hay Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis Semin Cancer Biol 19 2009 25 31
164. D. Rotin, B. Robinson, and I.F. Tannock Influence of hypoxia and an acidic environment on the metabolism and viability of cultured cells: potential implications for cell death in tumors Cancer Res 46 1986 2821 2826
165. R.R. Russell III, J.M. Mrus, J.I. Mommessin, and H. Taegtmeyer Compartmentation of hexokinase in rat heart. A critical factor for tracer kinetic analysis of myocardial glucose metabolism J Clin Invest 90 1992 1972 1977
166. T. Sakamoto, D. Niiya, and M. Seiki Targeting the Warburg effect that arises in tumor cells expressing membrane type-1 matrix metalloproteinase J Biol Chem 286 2011 14691 14704
167. I. Samudio, M. Fiegl, and M. Andreeff Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism Cancer Res 69 2009 2163 2166
168. I. Samudio, M. Fiegl, T. McQueen, K. Clise-Dwyer, and M. Andreeff The Warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation Cancer Res 68 2008 5198 5205
169. R. Scatena, P. Bottoni, A. Pontoglio, L. Mastrototaro, and B. Giardina Glycolytic enzyme inhibitors in cancer treatment Expert Opin Investig Drugs 17 2008 1533 1545
170. P.A. Schornack, and R.J. Gillies Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors Neoplasia 5 2003 135 145
171. M.A. Selak, S.M. Armour, E.D. MacKenzie, H. Boulahbel, D.G. Watson, K.D. Mansfield, Y. Pan, M.C. Simon, C.B. Thompson, and E. Gottlieb Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase Cancer Cell 7 2005 77 85
172. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 2003 721 732
173. G.L. Semenza HIF-1: upstream and downstream of cancer metabolism Curr Opin Genet Dev 20 2010 51 56
174. G.L. Semenza, P.H. Roth, H.M. Fang, and G.L. Wang Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1 J Biol Chem 269 1994 23757 23763
175. S. Sengupta, T.R. Peterson, and D.M. Sabatini Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress Mol Cell 40 2010 310 322
176. L.A. Shimoda, M. Fallon, S. Pisarcik, J. Wang, and G.L. Semenza HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes Am J Physiol Lung Cell Mol Physiol 291 2006 L941 L949
177. M.L. Silviera, B.P. Smith, J. Powell, and C. Sapienza Epigenetic differences in normal colon mucosa of cancer patients suggest altered dietary metabolic pathways Cancer Prev Res (Phila) 5 2012 374 384
178. P.K. Singh, K. Mehla, M.A. Hollingsworth, and K.R. Johnson Regulation of aerobic glycolysis by microRNAs in cancer Mol Cell Pharmacol 3 2011 125 134
179. A. Smerc, E. Sodja, and M. Legisa Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism PLoS One 6 2011
180. T. Song, X. Zhang, C. Wang, Y. Wu, W. Cai, J. Gao, and B. Hong MiR-138 suppresses expression of hypoxia-inducible factor 1alpha (HIF-1alpha) in clear cell renal cell carcinoma 786-O cells Asian Pac J Cancer Prev 12 2011 1307 1311
181. G.E. Staal, A. Kalff, E.C. Heesbeen, C.W. van Veelen, and G. Rijksen Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas Cancer Res 47 1987 5047 5051
182. Q. Sun, X. Chen, J. Ma, H. Peng, F. Wang, X. Zha, Y. Wang, Y. Jing, H. Yang, R. Chen, L. Chang, Y. Zhang, J. Goto, H. Onda, T. Chen, M.R. Wang, Y. Lu, H. You, D. Kwiatkowski, and H. Zhang Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth Proc Natl Acad Sci U S A 108 2011 4129 4134
183. Y. Sun, X. Zhao, Y. Zhou, and Y. Hu miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect Oncol Rep 28 2012 1346 1352 (LID - 10.3892/or)
184. T. Suzuki, A. Iwazaki, H. Katagiri, Y. Oka, J.L. Redpath, E.J. Stanbridge, and T. Kitagawa Enhanced expression of glucose transporter GLUT3 in tumorigenic HeLa cell hybrids associated with tumor suppressor dysfunction Eur J Biochem 262 1999 534 540
185. O. Szokoloczi, R. Schwab, I. Petak, L. Orfi, A. Pap, A.N. Eberle, T. Szuts, and G. Keril TT232, a novel signal transduction inhibitory compound in the therapy of cancer and inflammatory diseases J Recept Signal Transduct Res 25 2005 217 235
186. A. Taguchi, K. Yanagisawa, M. Tanaka, K. Cao, Y. Matsuyama, H. Goto, and T. Takahashi Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster Cancer Res 68 2008 5540 5545
187. C.H. Takimoto, and S.G. Arbuck Clinical status and optimal use of topotecan Oncology (Williston Park) 11 1997 1635 1646
188. H. Tang, M. Lee, O. Sharpe, L. Salamone, E.J. Noonan, C.D. Hoang, S. Levine, W.H. Robinson, and J.B. Shrager Oxidative stress-responsive microRNA-320 regulates glycolysis in diverse biological systems FASEB J 26 2012 4710 4721
189. W.P. Tsang, and T.T. Kwok The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras Carcinogenesis 30 2009 953 959
190. A. Tylicki, J. Czerniecki, P. Dobrzyn, A. Matanowska, A. Olechno, and S. Strumilo Modification of thiamine pyrophosphate dependent enzyme activity by oxythiamine in Saccharomyces cerevisiae cells Can J Microbiol 51 2005 833 839
191. M.S. Ullah, A.J. Davies, and A.P. Halestrap The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism J Biol Chem 281 2006 9030 9037
192. R. Varshney, B. Dwarakanath, and V. Jain Radiosensitization by 6-aminonicotinamide and 2-deoxy-d-glucose in human cancer cells Int J Radiat Biol 81 2005 397 408
193. O. Warburg On the origin of cancer cells Science 123 1956 309 314
194. P.S. Ward, and C.B. Thompson Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate Cancer Cell 21 2012 297 308
195. F. Weinberg, R. Hamanaka, W.W. Wheaton, S. Weinberg, J. Joseph, M. Lopez, B. Kalyanaraman, G.M. Mutlu, G.R. Budinger, and N.S. Chandel Mitochondrial metabolism and ros generation are essential for kras-mediated tumorigenicity Proc Natl Acad Sci U S A 107 2010 8788 8793
196. S. Welsh, R. Williams, L. Kirkpatrick, G. Paine-Murrieta, and G. Powis Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha Mol Cancer Ther 3 2004 233 244
197. A.K. Witkiewicz, D. Whitaker-Menezes, A. Dasgupta, N.J. Philp, Z. Lin, R. Gandara, S. Sneddon, U.E. Martinez-Outschoorn, F. Sotgia, and M.P. Lisanti Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers Cell Cycle 11 2012 1108 1117
198. A. Wolf, S. Agnihotri, J. Micallef, J. Mukherjee, N. Sabha, R. Cairns, C. Hawkins, and A. Guha Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme J Exp Med 208 2011 313 326
199. A. Wolf, S. Agnihotri, D. Munoz, and A. Guha Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme Neurobiol Dis 44 2011 84 91
200. K.K. Wong, J.A. Engelman, and L.C. Cantley Targeting the PI3K signaling pathway in cancer Curr Opin Genet Dev 20 2010 87 90
201. T.S. Wong, X.B. Liu, A. Chung-Wai Ho, A. Po-Wing Yuen, R. Wai-Man Ng, and W. Ignace Wei Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling Int J Cancer 123 2008 251 257
202. T.E. Wood, S. Dalili, C.D. Simpson, R. Hurren, X. Mao, F.S. Saiz, M. Gronda, Y. Eberhard, M.D. Minden, P.J. Bilan, A. Klip, R.A. Batey, and A.D. Schimmer A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death Mol Cancer Ther 7 2008 3546 3555
203. C. Xiao, L. Srinivasan, D.P. Calado, H.C. Patterson, B. Zhang, J. Wang, J.M. Henderson, J.L. Kutok, and K. Rajewsky Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes Nat Immunol 9 2008 405 414
204. J. Xu, B. Christian, and D.B. Jump Regulation of rat hepatic l-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist J Biol Chem 281 2006 18351 18362
205. M. Yamakuchi, M. Ferlito, and C.J. Lowenstein miR-34a repression of SIRT1 regulates apoptosis Proc Natl Acad Sci U S A 105 2008 13421 13426
206. S. Yasuda, S. Arii, A. Mori, N. Isobe, W. Yang, H. Oe, A. Fujimoto, Y. Yonenaga, H. Sakashita, and M. Imamura Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance J Hepatol 40 2004 117 123
207. E.T. Yeh SUMOylation and De-SUMOylation: wrestling with life's processes J Biol Chem 284 2009 8223 8227
208. S. Yu, Z. Lu, C. Liu, Y. Meng, Y. Ma, W. Zhao, J. Liu, J. Yu, and J. Chen miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer Cancer Res 70 2010 6015 6025
209. X. Zha, F. Wang, Y. Wang, S. He, Y. Jing, X. Wu, and H. Zhang Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis Cancer Res 71 2011 13 18
210. X.D. Zhang, E. Deslandes, M. Villedieu, L. Poulain, M. Duval, P. Gauduchon, L. Schwartz, and P. Icard Effect of 2-deoxy-d-glucose on various malignant cell lines in vitro Anticancer Res 26 2006 3561 3566
211. C. Zhang, M. Lin, R. Wu, X. Wang, B. Yang, A.J. Levine, W. Hu, and Z. Feng Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect Proc Natl Acad Sci U S A 108 2011 16259 16264
212. Q. Zhang, J. Pan, P.E. North, S. Yang, R.A. Lubet, Y. Wang, and M. You Aerosolized 3-bromopyruvate inhibits lung tumorigenesis without causing liver toxicity Cancer Prev Res (Phila) 5 2012 717 725
213. H. Zhang, D.Z. Qian, Y.S. Tan, K. Lee, P. Gao, Y.R. Ren, S. Rey, H. Hammers, D. Chang, R. Pili, C.V. Dang, J.O. Liu, and G.L. Semenza Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth Proc Natl Acad Sci U S A 105 2008 19579 19586
214. W.G. Zhao, S.N. Yu, Z.H. Lu, Y.H. Ma, Y.M. Gu, and J. Chen The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS Carcinogenesis 31 2010 1726 1733